Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 40

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Pseudomonas aeruginosa faces a fitness trade-off between mucosal colonization and antibiotic tolerance during airway infection

Meirelles, Lucas A., Vayena, Evangelia, Debache, Auriane, Schmidt, Eric, Rossy, Tamara, Distler, Tania, Hatzimanikatis, Vassily, Persat, Alexandre·2024·Nature Microbiology
DOI 10.1038/s41564-024-01842-3
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41564-024-01842-3

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 122

  1. Breidenstein, E. B. M., de la Fuente-Núñez, C. & Hancock, R. E. W. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19, 419–426 (2011). · DOI · Paper page
  2. Horcajada, J. P. et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin. Microbiol. Rev. 32, e00031–19 (2019). · DOI · Paper page
  3. Valderrey, A. D. et al. Chronic colonization by Pseudomonas aeruginosa of patients with obstructive lung diseases: cystic fibrosis, bronchiectasis, and chronic obstructive pulmonary disease. Diagn. Microbiol. Infect. Dis. 68, 20–27 (2010). · doi:10.1016/j.diagmicrobio.2010.04.008
  4. Fahy, J. V. & Dickey, B. F. Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233–2247 (2010). · DOI · Paper page
  5. Dolan, S. K. Current knowledge and future directions in developing strategies to combat Pseudomonas aeruginosa infection. J. Mol. Biol. 432, 5509–5528 (2020). · DOI
  6. Hibbert, T. M., Whiteley, M., Renshaw, S. A., Neill, D. R. & Fothergill, J. L. Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections. Crit. Rev. Microbiol. https://doi.org/10.1080/1040841X.2023.2285995 (2023). · DOI
  7. Rossi, E. et al. Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-020-00477-5 (2020). · DOI · Paper page
  8. Martínez-Solano, L., Macia, M. D., Fajardo, A., Oliver, A. & Martinez, J. L. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin. Infect. Dis. 47, 1526–1533 (2008). · DOI · Paper page
  9. Cao, P. et al. A Pseudomonas aeruginosa small RNA regulates chronic and acute infection. Nature 618, 358–364 (2023). · DOI · Paper page
  10. Jorth, P. et al. Regional isolation drives bacterial diversification within cystic fibrosis lungs. Cell Host Microbe 18, 307–319 (2015). · DOI · Paper page
  11. Friedman, L. & Kolter, R. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 186, 4457–4465 (2004). · DOI · Paper page
  12. Jenal, U. & Malone, J. Mechanisms of cyclic-di-GMP signaling in bacteria. Annu. Rev. Genet. 40, 385–407 (2006). · DOI · Paper page
  13. Hickman, J. W., Tifrea, D. F. & Harwood, C. S. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl Acad. Sci. USA 102, 14422–14427 (2005). · DOI · Paper page
  14. Ceri, H. et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37, 1771–1776 (1999). · DOI · Paper page
  15. Ciofu, O. & Tolker-Nielsen, T. Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents—how P. aeruginosa can escape antibiotics. Front. Microbiol. 10, 913 (2019). · DOI · Paper page
  16. de la Fuente-Nunez, C., Cesaro, A. & Hancock, R. E. W. Antibiotic failure: beyond antimicrobial resistance. Drug Resist. Updat. 71, 101012 (2023). · DOI · Paper page
  17. Walters, M. C., Roe, F., Bugnicourt, A., Franklin, M. J. & Stewart, P. S. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47, 317–323 (2003). · DOI · Paper page
  18. Levin-Reisman, I. et al. Antibiotic tolerance facilitates the evolution of resistance. Science 355, 826–830 (2017). · DOI · Paper page
  19. Santi, I., Manfredi, P., Maffei, E., Egli, A. & Jenal, U. Evolution of antibiotic tolerance shapes resistance development in chronic Pseudomonas aeruginosa infections. MBio 12, e03482–20 (2021). · DOI
  20. Harrison, J. J. et al. Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infections. PLoS Genet. 16, e1008848 (2020). · DOI
  21. Jennings, L. K. et al. Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies. Cell Rep. 34, 108782 (2021). · DOI · Paper page
  22. Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 47, 57–64 (2015). · DOI · Paper page
  23. López-Jiménez, A. T. & Mostowy, S. Emerging technologies and infection models in cellular microbiology. Nat. Commun. 12, 6764 (2021).
  24. Shi, D., Mi, G., Wang, M. & Webster, T. J. In vitro and ex vivo systems at the forefront of infection modeling and drug discovery. Biomaterials 198, 228–249 (2019). · DOI
  25. Wagner, C. E., Wheeler, K. M. & Ribbeck, K. Mucins and their role in shaping the functions of mucus barriers. Annu. Rev. Cell Dev. Biol. 34, 189–215 (2018). · DOI · Paper page
  26. Rossy, T. et al. Pseudomonas aeruginosa type IV pili actively induce mucus contraction to form biofilms in tissue-engineered human airways. PLoS Biol. 21, e3002209 (2023). · DOI
  27. Lewin, G. R. et al. Application of a quantitative framework to improve the accuracy of a bacterial infection model. Proc. Natl Acad. Sci. USA 120, e2221542120 (2023). · DOI
  28. Palmer, K. L., Mashburn, L. M., Singh, P. K. & Whiteley, M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187, 5267–5277 (2005). · DOI · Paper page
  29. Palmer, K. L., Aye, L. M. & Whiteley, M. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189, 8079–8087 (2007). · DOI · Paper page
  30. Leoni Swart, A. et al. Pseudomonas aeruginosa breaches respiratory epithelia through goblet cell invasion in a microtissue model. Nat. Microbiol. https://doi.org/10.1038/s41564-024-01718-6 (2024). · DOI
  31. Hasan, S., Sebo, P. & Osicka, R. A guide to polarized airway epithelial models for studies of host–pathogen interactions. FEBS J. 285, 4343–4358 (2018). · DOI
  32. Cain, A. K. et al. A decade of advances in transposon-insertion sequencing. Nat. Rev. Genet. 21, 526–540 (2020). · DOI · Paper page
  33. Winstanley, C., O’Brien, S. & Brockhurst, M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 24, 327–337 (2016). · DOI · Paper page
  34. Gao, C. et al. Lactate utilization is regulated by the FadR-type regulator LldR in Pseudomonas aeruginosa. J. Bacteriol. 194, 2687–2692 (2012). · DOI
  35. El Husseini, N. et al. Characterization of the Entner–Doudoroff pathway in Pseudomonas aeruginosa catheter-associated urinary tract infections. J. Bacteriol. https://doi.org/10.1128/jb.00361-23 (2023). · doi:10.1128/jb.00361-23
  36. McMorran, B. J., Merriman, M. E., Rombel, I. T. & Lamont, I. L. Characterisation of the pvdE gene which is required for pyoverdine synthesis in Pseudomonas aeruginosa. Gene 176, 55–59 (1996). · DOI
  37. Bartell, J. A. et al. Reconstruction of the metabolic network of Pseudomonas aeruginosa to interrogate virulence factor synthesis. Nat. Commun. 8, 14631 (2017). · DOI
  38. McShane, A. et al. Mucus. Curr. Biol. 31, R938–R945 (2021). · DOI
  39. Maurice, N. M., Bedi, B. & Sadikot, R. T. Pseudomonas aeruginosa biofilms: host response and clinical implications in lung infections. Am. J. Respir. Cell Mol. Biol. 58, 428–439 (2018). · DOI · Paper page
  40. Kong, W. et al. ChIP-seq reveals the global regulator AlgR mediating cyclic di-GMP synthesis in Pseudomonas aeruginosa. Nucleic Acids Res. 43, 8268–8282 (2015). · DOI
  41. Petrova, O. E., Cherny, K. E. & Sauer, K. The Pseudomonas aeruginosa diguanylate cyclase GcbA, a homolog of P. fluorescens GcbA, promotes initial attachment to surfaces, but not biofilm formation, via regulation of motility. J. Bacteriol. 196, 2827–2841 (2014). · DOI
  42. Kuchma, S. L. et al. BifA, a cyclic-Di-GMP phosphodiesterase, inversely regulates biofilm formation and swarming motility by Pseudomonas aeruginosa PA14. J. Bacteriol. 189, 8165–8178 (2007). · DOI · Paper page
  43. Manner, C. et al. A genetic switch controls Pseudomonas aeruginosa surface colonization. Nat. Microbiol. 8, 1520–1533 (2023). · DOI
  44. Roy, A. B., Petrova, O. E. & Sauer, K. The phosphodiesterase DipA (PA5017) is essential for Pseudomonas aeruginosa biofilm dispersion. J. Bacteriol. 194, 2904–2915 (2012). · DOI · Paper page
  45. Muggeo, A., Coraux, C. & Guillard, T. Current concepts on Pseudomonas aeruginosa interaction with human airway epithelium. PLoS Pathog. 19, e1011221 (2023). · DOI
  46. Cont, A., Rossy, T., Al-Mayyah, Z. & Persat, A. Biofilms deform soft surfaces and disrupt epithelia. Elife 9, e56533 (2020). · DOI · Paper page
  47. Meirelles, L. A., Perry, E. K., Bergkessel, M. & Newman, D. K. Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics. PLoS Biol. 19, e3001093 (2021). · DOI
  48. Purssell, A. & Poole, K. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa. Microbiology 159, 2058–2073 (2013). · DOI
  49. Matsuo, Y., Eda, S., Gotoh, N., Yoshihara, E. & Nakae, T. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol. Lett. 238, 23–28 (2004).
  50. Laborda, P. et al. Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. Nat. Commun. 15, 2584 (2024). · DOI
  51. Lister, P. D., Wolter, D. J. & Hanson, N. D. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22, 582–610 (2009). · DOI · Paper page
  52. Fair, R. J. & Tor, Y. Antibiotics and bacterial resistance in the 21st century. Perspect. Med. Chem. 6, 25–64 (2014).
  53. Bulitta, J. B. et al. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling. Antimicrob. Agents Chemother. 59, 2315–2327 (2015). · DOI
  54. Clark, S. T. et al. Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis. Sci. Rep. 5, 10932 (2015). · DOI
  55. Mowat, E. et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183, 1674–1679 (2011). · DOI · Paper page
  56. O’Brien, S. et al. High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections. BMC Microbiol. 17, 30 (2017). · DOI
  57. Bartell, J. A. et al. Evolutionary highways to persistent bacterial infection. Nat. Commun. 10, 629 (2019). · DOI
  58. Armbruster, C. R. et al. Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis. Cell Rep. 37, 109829 (2021). · DOI
  59. Bensel, T. et al. Lactate in cystic fibrosis sputum. J. Cyst. Fibros. 10, 37–44 (2011). · DOI
  60. Davey, L. E. et al. A genetic system for Akkermansia muciniphila reveals a role for mucin foraging in gut colonization and host sterol biosynthesis gene expression. Nat. Microbiol. 8, 1450–1467 (2023). · DOI
  61. Flynn, J. M., Phan, C. & Hunter, R. C. Genome-wide survey of Pseudomonas aeruginosa PA14 reveals a role for the glyoxylate pathway and extracellular proteases in the utilization of mucin. Infect. Immun. 85, e00182–17 (2017). · DOI
  62. Hoet, P. H. & Nemery, B. Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L417–L433 (2000). · doi:10.1152/ajplung.2000.278.3.l417
  63. Liu, Z., Hossain, S. S., Morales Moreira, Z. & Haney, C. H. Putrescine and its metabolic precursor arginine promote biofilm and c-di-GMP synthesis in Pseudomonas aeruginosa. J. Bacteriol. 204, e0029721 (2022). · doi:10.1128/jb.00297-21
  64. Barth, A. L. & Pitt, T. L. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa. J. Med. Microbiol. 45, 110–119 (1996). · DOI · Paper page
  65. Thomas, S. R., Ray, A., Hodson, M. E. & Pitt, T. L. Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax 55, 795–797 (2000). · DOI
  66. DePas, W. H. et al. Exposing the three-dimensional biogeography and metabolic states of pathogens in cystic fibrosis sputum via hydrogel embedding, clearing, and rRNA labeling. MBio 7, e00796–16 (2016). · DOI
  67. Cantin, A. M., Hartl, D., Konstan, M. W. & Chmiel, J. F. Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J. Cyst. Fibros. 14, 419–430 (2015). · DOI · Paper page
  68. Marvig, R. L. et al. Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients. BMC Microbiol. 15, 218 (2015). · DOI
  69. Stanford, G. E., Dave, K. & Simmonds, N. J. Pulmonary exacerbations in adults with cystic fibrosis: a grown-up issue in a changing cystic fibrosis landscape. Chest 159, 93–102 (2021). · DOI · Paper page
  70. Woo, J. K. K., Webb, J. S., Kirov, S. M., Kjelleberg, S. & Rice, S. A. Biofilm dispersal cells of a cystic fibrosis Pseudomonas aeruginosa isolate exhibit variability in functional traits likely to contribute to persistent infection. FEMS Immunol. Med. Microbiol. 66, 251–264 (2012). · DOI
  71. Sousa, A. M. & Pereira, M. O. Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs—a review. Pathogens 3, 680–703 (2014). · DOI · Paper page
  72. Stewart, P. S. et al. Conceptual model of biofilm antibiotic tolerance that integrates phenomena of diffusion, metabolism, gene expression, and physiology. J. Bacteriol. 201, e00307–e00319 (2019). · DOI
  73. Tseng, B. S. et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ. Microbiol. 15, 2865–2878 (2013). · DOI · Paper page
  74. Winans, J. B., Wucher, B. R. & Nadell, C. D. Multispecies biofilm architecture determines bacterial exposure to phages. PLoS Biol. 20, e3001913 (2022). · DOI
  75. Thurlow, L. R. et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186, 6585–6596 (2011). · DOI · Paper page
  76. Rowe, W. J., Lebman, D. A. & Ohman, D. E. Mechanism of resistance to phagocytosis and pulmonary persistence in mucoid Pseudomonas aeruginosa. Front. Cell Infect. Microbiol. 13, 1125901 (2023). · DOI
  77. Mishra, M. et al. Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization. Cell Microbiol. 14, 95–106 (2012). · DOI · Paper page
  78. Malhotra, S., Limoli, D. H., English, A. E., Parsek, M. R. & Wozniak, D. J. Mixed communities of mucoid and nonmucoid Pseudomonas aeruginosa exhibit enhanced resistance to host antimicrobials. MBio 9, e00275–18 (2018). · DOI
  79. Köhler, T. et al. Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa. Nat. Commun. 14, 3629 (2023).
  80. Strathdee, S. A., Hatfull, G. F., Mutalik, V. K. & Schooley, R. T. Phage therapy: from biological mechanisms to future directions. Cell 186, 17–31 (2023). · DOI · Paper page
  81. Mishra, R. et al. Mechanopathology of biofilm-like Mycobacterium tuberculosis cords. Cell 186, 5135–5150.e28 (2023). · DOI
  82. Luckett, K. A. & Ganesh, K. Engineering the immune microenvironment into organoid models. Annu. Rev. Cancer Biol. 7, 1972–1988.e16 (2023). · DOI
  83. Holloway, B. W. & Morgan, A. F. Genome organization in Pseudomonas. Annu. Rev. Microbiol. 40, 79–105 (1986). · DOI · Paper page
  84. Hoang, T. T., Karkhoff-Schweizer, R. R., Kutchma, A. J. & Schweizer, H. P. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212, 77–86 (1998). · DOI · Paper page
  85. Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009). · DOI · Paper page
  86. Simon, R., Priefer, U. & Pühler, A. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Nat. Biotechnol. 1, 784–791 (1983). · DOI · Paper page
  87. Choi, K.-H. & Schweizer, H. P. mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat. Protoc. 1, 153–161 (2006). · DOI · Paper page
  88. Rybtke, M. T. et al. Fluorescence-based reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 78, 5060–5069 (2012). · DOI · Paper page
  89. Jacobs, M. A. et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 100, 14339–14344 (2003). · DOI · Paper page
  90. Basta, D. W., Bergkessel, M. & Newman, D. K. Identification of fitness determinants during energy-limited growth arrest in Pseudomonas aeruginosa. MBio 8, e01170–17 (2017). · DOI
  91. Fulcher, M. L. & Randell, S. H. Human nasal and tracheo-bronchial respiratory epithelial cell culture. Methods Mol. Biol. 945, 109–121 (2013). · DOI · Paper page
  92. Jiménez-Torres, J. A., Peery, S. L., Sung, K. E. & Beebe, D. J. Lumenext: a practical method to pattern luminal structures in ECM gels. Adv. Health. Mater. 5, 198–204 (2016). · DOI
  93. Chen, Y. et al. Validation of human small airway measurements using endobronchial optical coherence tomography. Respir. Med. 109, 1446–1453 (2015). · doi:10.1016/j.rmed.2015.09.006
  94. Horsfield, K. & Cumming, G. Morphology of the bronchial tree in man. J. Appl. Physiol. 24, 373–383 (1968). · DOI · Paper page
  95. DeJesus, M. A., Ambadipudi, C., Baker, R., Sassetti, C. & Ioerger, T. R. TRANSIT—a software tool for Himar1 TnSeq analysis. PLoS Comput. Biol. 11, e1004401 (2015). · DOI · Paper page
  96. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009). · DOI · Paper page
  97. DeJesus, M. A. & Ioerger, T. R. Normalization of transposon-mutant library sequencing datasets to improve identification of conditionally essential genes. J. Bioinform. Comput. Biol. 14, 1642004 (2016). · DOI
  98. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009). · DOI · Paper page
  99. Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216–W221 (2022). · DOI · Paper page
  100. McKinney, W. Data structures for statistical computing in python. in Proceedings of the 9th Python in Science Conference 56–61. https://doi.org/10.25080/Majora-92bf1922-00a (SciPy, 2010). · DOI · Paper page
  101. Pedregosa, F. et al. AnchorScikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
  102. EUCAST Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 9, ix–xv (2003). · DOI · Paper page
  103. Meirelles, L. A. & Newman, D. K. Phenazines and toxoflavin act as interspecies modulators of resilience to diverse antibiotics. Mol. Microbiol. 117, 1384–1404 (2022). · DOI
  104. Masid, M., Ataman, M. & Hatzimanikatis, V. Analysis of human metabolism by reducing the complexity of the genome-scale models using redHUMAN. Nat. Commun. 11, 2821 (2020).
  105. Jankowski, M. D., Henry, C. S., Broadbelt, L. J. & Hatzimanikatis, V. Group contribution method for thermodynamic analysis of complex metabolic networks. Biophys. J. 95, 1487–1499 (2008). · DOI · Paper page
  106. Salvy, P. et al. pyTFA and matTFA: a Python package and a Matlab toolbox for thermodynamics-based flux analysis. Bioinformatics 35, 167–169 (2019). · DOI
  107. Soh, K. C. & Hatzimanikatis, V. Network thermodynamics in the post-genomic era. Curr. Opin. Microbiol. 13, 350–357 (2010). · DOI
  108. Soh, K. C. & Hatzimanikatis, V. Constraining the flux space using thermodynamics and integration of metabolomics data. Methods Mol. Biol. 1191, 49–63 (2014). · DOI
  109. Thiele, I. et al. A community effort towards a knowledge-base and mathematical model of the human pathogen Salmonella Typhimurium LT2. BMC Syst. Biol. 5, 8 (2011). · DOI
  110. Dulbecco, R. & Freeman, G. Plaque production by the polyoma virus. Virology 8, 396–397 (1959). · DOI · Paper page
  111. Wheeler, K. M. et al. Mucin glycans attenuate the virulence of Pseudomonas aeruginosa in infection. Nat. Microbiol. 4, 2146–2154 (2019). · DOI · Paper page
  112. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012). · DOI · Paper page
  113. Krull, A., Buchholz, T.-O. & Jug, F. Noise2Void - Learning denoising from single noisy images. in 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) 2124–2132 (IEEE, 2019). · DOI · Paper page
  114. Ho, T. K. Random decision forests. in Proceedings of 3rd International Conference on Document Analysis and Recognition 278–282 (IEEE Comput. Soc. Press, 1995).
  115. van der Walt, S. et al. scikit-image: image processing in Python. PeerJ 2, e453 (2014). · doi:10.7717/peerj.453
  116. Fiorio, C. & Gustedt, J. Two linear time Union-Find strategies for image processing. Theor. Comput. Sci. 154, 165–181 (1996). · doi:10.1016/0304-3975(94)00262-2
  117. Wu, K., Otoo, E. & Shoshani, A. Optimizing connected component labeling algorithms. in Medical Imaging 2005: Image Processing (eds Fitzpatrick, J. M. & Reinhardt, J. M.) 5747, 1965 (SPIE, 2005). · doi:10.1117/12.596105
  118. Burger, W. & Burge, M. J. Principles of Digital Image Processing (Springer, 2009); https://doi.org/10.1007/978-1-84800-195-4 · DOI · Paper page
  119. Reiss, T. H. Recognizing Planar Objects Using Invariant Image Features (Springer, 1993); https://doi.org/10.1007/BFb0017553 · doi:10.1007/bfb0017553
  120. Harris et al. Array programming with NumPy. Nature 585, 357–362 (2020). · DOI · Paper page
  121. Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020). · DOI · Paper page
  122. Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007). · DOI · Paper page

Cited by

See all 40

Metadata

Authors
Meirelles, L. A., Vayena, E., Debache, A., Schmidt, E., Rossy, T., Distler, T., Hatzimanikatis, V., & Persat, A.
Venue
Nature Microbiology
Publisher
Springer Science and Business Media LLC
Published
2024-10-25
Volume
9
Issue
12
Pages
3284-3303
ISSN
2058-5276
DOI
10.1038/s41564-024-01842-3
Cited by
40
References
5
Language
en
Licence
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_189084, 200021_188623)
  • Swiss National Science Foundation - NCCR AntiResist
  • European Molecular Biology Organization (ALTF 12-2022)
  • Swiss National Science Foundation - NCCR Microbiomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pseudomonas aeruginosa faces a fitness trade-off between mucosal colonization and antibiotic tolerance during airway infection. https://app.cochat.ai/papers/10.1038/s41564-024-01842-3
The paper
Meirelles, L. A., Vayena, E., Debache, A., Schmidt, E., Rossy, T., Distler, T., Hatzimanikatis, V., & Persat, A. (2024). Pseudomonas aeruginosa faces a fitness trade-off between mucosal colonization and antibiotic tolerance during airway infection. Nature Microbiology. https://doi.org/10.1038/s41564-024-01842-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.